Hepatitis B Topics HBV Disease Progression
AASLD: Upping Entecavir Dose Does Not Improve Hepatitis B Treatment Response
- Details
- Category: HBV Treatment
- Published on Tuesday, 29 November 2011 00:00
- Written by Liz Highleyman
Doubling the usual dose of entecavir (Baraclude) did not increase its effectiveness for treating chronic hepatitis B, according to a study presented at the 62nd Annual Meeting of the American Association for the Study of Liver Disease (AASLD 2011) this month in San Francisco.
AASLD: Good Response to Entecavir Reduces Risk of Hepatitis B Liver Disease Progression
- Details
- Category: HBV Treatment
- Published on Tuesday, 22 November 2011 00:00
- Written by Liz Highleyman
Chronic hepatitis B patients who achieve HBV DNA viral load suppression on entecavir (Baraclude) have a lower risk of liver failure, hepatocellular carcinoma, and death than non-responders, according to study findings presented this month at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2011) in San Francisco.
Changes Proposed for Allocation of Donated Livers
- Details
- Category: Liver Transplant/Artificial Liver
- Published on Thursday, 01 September 2011 00:00
- Written by Press Release
For some patients transplantation is the only treatment for advanced liver disease due to chronic hepatitis B, hepatitis C, liver cancer, alcoholism, or other causes. But the supply of donor livers does not meet the demand, meaning that many people die while on a waiting list. As described in the September 2011 issue of Liver Transplantation, experts have been meeting for the past 2 years to develop a modified allocation system that aims to reduce wait-list mortality.
AASLD: Engineered Poxvirus Shows Promise for Treating Advanced Liver Cancer
- Details
- Category: Liver Cancer/HCC
- Published on Tuesday, 08 November 2011 00:00
- Written by Press Release
A genetically engineered vaccinia poxvirus (JX-594) can rapidly destroy tumors and prolong survival of people with advanced hepatocellular carcinoma (HCC), according to a late-breaker presentation at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2011) this week in San Francisco.
Hepatitis Delta Found in 15% of HIV/HBV Coinfected People, Increases Risk of Death
- Details
- Category: Hepatitis Delta (HDV)
- Published on Thursday, 01 September 2011 00:00
- Written by Liz Highleyman
Approximately 15% of people with HIV who test positive for hepatitis B surface antigen (HBsAg) also carry hepatitis delta virus (HDV), a defective virus that can only replicate in the presence of hepatitis B virus (HBV) but can lead to more severe liver damage, according to a recent European study.
Occult Hepatitis B Infection May Be the Cause of Unexplained Liver Cancer
- Details
- Category: Occult HBV
- Published on Tuesday, 06 September 2011 00:00
- Written by Liz Highleyman
Hepatitis B virus (HBV) infection may cause more cases of hepatocellular carcinoma (HCC) than estimated if occult or "hidden" HBV is taken into account, according to a study described in the September 2, 2011, issue of Hepatology.
High HBV Viral Load Predicts Liver Fibrosis and Cancer
- Details
- Category: HBV Disease Progression
- Published on Tuesday, 30 August 2011 00:00
- Written by Liz Highleyman
High hepatitis B virus (HBV) DNA levels were associated with worse liver fibrosis, hepatitis reactivation, and development of hepatocellular carcinoma (HCC) in hepatitis B "e" antigen (HBeAg) negative patients in 2 recent studies described in the July 2011 Journal of Viral Hepatitis.
More Articles...
- One-quarter of Patients Clear Hepatitis Delta with Pegylated Interferon
- Does Previous Hepatitis B Exposure Increase Liver Cancer Risk?
- Artificial Liver Device Improves Survival for Hepatitis B and C Patients with Decompensated Disease
- Alcohol and Diabetes Increase Risk of Liver Disease Progression in Hepatitis B Patients
- Androgen Receptor May Explain Why More Men with Hepatitis B Develop Liver Cancer
Web Design and Development by